Viewing Study NCT00204659


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-01-18 @ 4:24 AM
Study NCT ID: NCT00204659
Status: COMPLETED
Last Update Posted: 2008-10-20
First Post: 2005-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Sponsor: University Hospital Tuebingen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Gastric Diffuse-Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rituximab View
None CHOP View
None DLBCL View
None gastric lymphoma View